Gensight Biologics SA
PAR:SIGHT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gensight Biologics SA
PAR:SIGHT
|
FR |
|
Speed Commerce Inc
OTC:SPDC
|
US |
|
Yunji Inc
NASDAQ:YJ
|
CN |
|
Biomea Fusion Inc
NASDAQ:BMEA
|
US |
|
B
|
Britvic PLC
OTC:BTVCF
|
UK |
|
T
|
Tropical Canning Thailand PCL
SET:TC
|
TH |
|
Applied Minerals Inc
OTC:AMNL
|
US |
|
S
|
Suprema ID Inc
KOSDAQ:317770
|
KR |
|
K
|
Kawagishi Bridge Works Co Ltd
TSE:5921
|
JP |
|
Blue Energy Ltd
ASX:BLU
|
AU |
|
Frontier Group Holdings Inc
NASDAQ:ULCC
|
US |
|
A
|
Advance Information Marketing Bhd
KLSE:AIM
|
MY |
|
ForFarmers NV
AEX:FFARM
|
NL |
|
Zhejiang EV-Tech Co Ltd
SZSE:301607
|
CN |
|
D
|
DongKoo Bio & Pharma Co Ltd
KOSDAQ:006620
|
KR |
|
Eagle Football Group SA
PAR:EFG
|
FR |
Bankruptcy Probability
Gensight Biologics SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Gensight Biologics SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Gensight Biologics SA
PAR:SIGHT
|
23.5m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
453.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Gensight Biologics SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Gensight Biologics SA has total debt of 9.2m EUR. This includes both short-term (0 EUR) and long-term (9.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
